Preliminary pharmacological studies with 1,6-dimesyl-2,3-4,5-dianhydro-L-iditol in patients with cancer.
D000477:Alkylating Agents / Q000627:therapeutic use*; D006601:Hexoses; D006801:Humans; D008698:Mesylates / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D013402:Sugar Alcohols / Q000627:therapeutic use*
D000477:Alkylating Agents; D006601:Hexoses; D008698:Mesylates; D013402:Sugar Alcohols